Catalent completes acquisition of Bone Therapeutics’ cell therapy manufacturing subsidiary SCTS
The gross proceeds of the deal are €12 million
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bone Therapeutics
Bone Therapeutics commences research on combined cell-matrix products
€1 million funding secured from the Walloon Region to investigate these innovative products for the treatment of large bone…